{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:53:16Z","timestamp":1787237596037,"version":"build-2736575974"},"reference-count":16,"publisher":"Scientific Scholar","content-domain":{"domain":["indianjnephrol.org"],"crossmark-restriction":true},"short-container-title":["Indian J Nephrol"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Kidney transplant recipients (KTRs) are at higher risk for infections, including parvovirus B19 (PVB19). This virus typically presents within the first-year posttransplant, causing anemia and potentially leading to increased morbidity and graft dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Charts of patients undergoing kidney transplantation between May 2013 and March 2022 were reviewed. Twenty-one patients had PVB19. Their clinical presentation, laboratory parameters, and outcomes were studied. The diagnosis of PVB19 was established by PVB19 DNA Polymerase Chain Reaction (PCR) and bone marrow examination (BME).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Prevalence of PVB19 disease was 1.9% (21\/1164) with a median onset time of 39 days posttransplantation. The most frequent clinical symptoms were fatigue reported by 76% of patients, followed by fever (47%), dyspnea (23%), and myalgia (33%). All patients (100%) developed anemia, while leukopenia and thrombocytopenia were observed in 14% and 9.5% of patients, respectively. Graft dysfunction was observed in 61.9% (13\/21) patients. Diagnosis was confirmed by PCR in 20 out of 21 patients. One patient had a typical viral inclusion on BME. Immunosuppression, especially antiproliferative, was reduced in all patients. Eight patients received intravenous immunoglobulin, eight received packed cell blood transfusion, and seven received erythropoietin therapy. All patients recovered, with a median time of 30 days for hemoglobin levels to normalize. One patient had graft loss secondary to graft rejection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>PVB19, while uncommon, can be a significant cause of refractory anemia, particularly within the first-year posttransplant. Diagnosing PVB19 infection with PCR is crucial, and the primary treatment involves reducing immunosuppressants, especially antiproliferative agents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.25259\/ijn_127_2024","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T02:17:12Z","timestamp":1724897832000},"page":"511-515","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Parvovirus B19 Infection as a Cause of Refractory Anemia in Kidney Transplant Recipients: A Case Series"],"prefix":"10.25259","volume":"35","author":[{"given":"Umapati N","family":"Hegde","sequence":"first","affiliation":[{"name":"Department of Nephrology, Muljibhai Patel Urological Hospital, Nadiad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Mittal","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Medanta Institute of Kidney and Urology, Medanta\u2014The Medicity, Gurgaon, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sishir","family":"Gang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Muljibhai Patel Urological Hospital, Nadiad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Konnur","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Muljibhai Patel Urological Hospital, Nadiad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardik","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Muljibhai Patel Urological Hospital, Nadiad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"10.25259\/IJN_127_2024\/ref-1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/s0140-6736(75)91074-0","article-title":"Parvovirus-like particles in human sera","volume":"305","author":"Cossart","year":"1975","journal-title":"Lancet"},{"key":"10.25259\/IJN_127_2024\/ref-2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1099\/00222615-25-2-151","article-title":"The prevalence of antibody to human parvovirus B19 in England and Wales","volume":"25","author":"Cohen","year":"1988","journal-title":"J Med Microbiol"},{"key":"10.25259\/IJN_127_2024\/ref-3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/s0369-8114(02)00307-3","article-title":"Persistence of human parvovirus B19 in human tissues","volume":"50","author":"S\u00f6derlund-Venermo","year":"2002","journal-title":"Pathol Biol (Paris)"},{"key":"10.25259\/IJN_127_2024\/ref-4","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1399-0012.2005.00415.x","article-title":"Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients","volume":"19","author":"Ki","year":"2005","journal-title":"Clin Transplant"},{"key":"10.25259\/IJN_127_2024\/ref-5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.12659\/AOT.913663","article-title":"Pure red cell aplasia after kidney transplantation: Parvovirus B19 culprit or coincidence?","volume":"24","author":"Pabisiak","year":"2019","journal-title":"Ann Transplant"},{"key":"10.25259\/IJN_127_2024\/ref-6","doi-asserted-by":"publisher","first-page":"e28387","DOI":"10.1097\/MD.0000000000028387","article-title":"Parvovirus B19-induced severe anemia in heart transplant recipient","volume":"100","author":"Xu","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.25259\/IJN_127_2024\/ref-7","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1093\/ndt\/gfm531","article-title":"Relapsing severe anaemia due to primary parvovirus B19 infection after renal transplantation: A case report and review of the literature","volume":"22","author":"Beckhoff","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.25259\/IJN_127_2024\/ref-8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1086\/504812","article-title":"Parvovirus B19 infection after transplantation: A review of 98 cases","volume":"43","author":"Eid","year":"2006","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.25259\/IJN_127_2024\/ref-9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/s1386-6532(02)00104-x","article-title":"B19 virus infection in renal transplant recipients","volume":"26","author":"Cavallo","year":"2003","journal-title":"J Clin Virol Off Publ Pan Am Soc Clin Virol"},{"key":"10.25259\/IJN_127_2024\/ref-10","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1681\/ASN.V1161132","article-title":"Thrombotic microangiopathy associated with parvovirus b 19 infection after renal transplantation","volume":"11","author":"Murer","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.25259\/IJN_127_2024\/ref-11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1034\/j.1600-6143.2002.20505.x","article-title":"Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrence","volume":"2","author":"Barsoum","year":"2002","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"10.25259\/IJN_127_2024\/ref-12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1034\/j.1399-3062.2002.01007.x","article-title":"Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction","volume":"4","author":"Yango","year":"2002","journal-title":"Transpl Infect Dis Off J Transplant Soc"},{"key":"10.25259\/IJN_127_2024\/ref-13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s100960050406","article-title":"Occurrence and clinical role of active parvovirus B19 infection in transplant recipients","volume":"18","author":"Gallinella","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"key":"10.25259\/IJN_127_2024\/ref-14","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1097\/00007890-200005270-00043","article-title":"Parvovirus B19 in kidney transplant patients","volume":"69","author":"Zolnourian","year":"2000","journal-title":"Transplantation"},{"key":"10.25259\/IJN_127_2024\/ref-15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4103\/UA.UA_89_19","article-title":"Epidemiology of parvovirus B19 and anemia among kidney transplant recipients: A meta-analysis","volume":"12","author":"Thongprayoon","year":"2020","journal-title":"Urol Ann"},{"key":"10.25259\/IJN_127_2024\/ref-16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJM198908243210807","article-title":"Pure red-cell aplasia of 10 years\u2019 duration due to persistent parvovirus b19 infection and its cure with immunoglobulin therapy","volume":"321","author":"Kurtzman","year":"1989","journal-title":"N Engl J Med"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/indianjnephrol.org\/parvovirus-b19-infection-as-a-cause-of-refractory-anemia-in-kidney-transplant-recipients-a-case-series\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/indianjnephrol.org\/parvovirus-b19-infection-as-a-cause-of-refractory-anemia-in-kidney-transplant-recipients-a-case-series\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T12:22:56Z","timestamp":1751286176000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/parvovirus-b19-infection-as-a-cause-of-refractory-anemia-in-kidney-transplant-recipients-a-case-series\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":16,"alternative-id":["10.25259\/IJN_127_2024"],"URL":"https:\/\/doi.org\/10.25259\/ijn_127_2024","relation":{},"ISSN":["1998-3662","0971-4065"],"issn-type":[{"value":"1998-3662","type":"electronic"},{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,29]]},"article-number":"511"}}